These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 19685394)
21. [Clinical aspects of botulism in cattle]. Hofmann W Dtsch Tierarztl Wochenschr; 1999 Feb; 106(2):74. PubMed ID: 10085585 [No Abstract] [Full Text] [Related]
22. [From botulism to cosmetics--a story of a drug]. Aquilonius SM Lakartidningen; 2000 Mar; 97(11):1228-31. PubMed ID: 10771540 [No Abstract] [Full Text] [Related]
23. Learning from the past: historical aspects of bacterial toxins as pharmaceuticals. Pellett S Curr Opin Microbiol; 2012 Jun; 15(3):292-9. PubMed ID: 22651975 [TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin: from poison to pharmaceutical. The history of a poison that became useful to mankind. Kreyden OP Curr Probl Dermatol; 2002; 30():94-100. PubMed ID: 12471702 [No Abstract] [Full Text] [Related]
26. Use of enzyme-linked immunoassays for antibody to types C and D botulinum toxins for investigations of botulism in cattle. Gregory AR; Ellis TM; Jubb TF; Nickels RJ; Cousins DV Aust Vet J; 1996 Feb; 73(2):55-61. PubMed ID: 8660200 [TBL] [Abstract][Full Text] [Related]
28. Botulism in an Oregon dairy cow herd. Gray TC; Bulgin MS J Am Vet Med Assoc; 1982 Jan; 180(2):160-2. PubMed ID: 7061313 [TBL] [Abstract][Full Text] [Related]
35. Application of PCR for detection of Clostridium botulinum type D in bovine samples. Chaffer M; Baum M; Grinberg K; Molad T; Elad D J Vet Med B Infect Dis Vet Public Health; 2006 Feb; 53(1):45-7. PubMed ID: 16460356 [TBL] [Abstract][Full Text] [Related]
36. Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc. Dressler D; Hallett M Eur J Neurol; 2006 Feb; 13 Suppl 1():11-5. PubMed ID: 16417592 [TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin. From poison to medicine. Davis LE West J Med; 1993 Jan; 158(1):25-9. PubMed ID: 8470380 [TBL] [Abstract][Full Text] [Related]
38. [Botulinum toxin useful against writer's cramp]. Kruisdijk JJ; Koelman JH; Ongerboer de Visser BW; de Haan RJ; Speelman JD Ned Tijdschr Geneeskd; 2009 Jan; 153(4):118-23. PubMed ID: 19348131 [No Abstract] [Full Text] [Related]
39. The use of botulinum toxin in the treatment of refractory overactive bladder. Mucksavage P; Smith AL; Moy ML Ostomy Wound Manage; 2006 Dec; 52(12):28, 30, 32-3. PubMed ID: 17219700 [No Abstract] [Full Text] [Related]